Red Queen Therapeutics is a clinical-stage company working to deliver important and accessible new treatment options for a broad range of virus-borne illnesses including influenzas, coronaviruses, and other current and emerging pathogens.

Co-founded by Apple Tree Partners (ATP) and biomedical researcher Loren Walensky, M.D., Ph.D., Red Queen is applying its proprietary stapled lipopeptide technology to develop and deliver new treatments for a broad range of viruses, including coronaviruses, influenzas, and other enveloped viruses. For more information, please visit redqueentx.com.

NOTICE: Red Queen Therapeutics does not make unsolicited job offers by email, LinkedIn message, or any other means. Please do not respond to or interact with any such messages purporting to have issued from or on behalf of Red Queen Therapeutics.

Red Queen Therapeutics

Org chart

Teams

Offices